日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2

CHO 生产的 RBD-Fc 亚单位疫苗与替代佐剂一起产生针对 SARS-CoV-2 的免疫反应

期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0288486
Sedthawut Laotee, Methawee Duangkaew, Araya Jivapetthai, Kittipan Tharakhet, Papatsara Kaewpang, Eakachai Prompetchara, Supaporn Phumiamorn, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somsaard, Sittiruk Roytrakul, Parichat Duangkhae, Boonsri Ongpipattanakul, Patanachai Limpikirati, Natap
代谢
免疫
心血管
新冠
发表日期：2023
文献求助 收藏

Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population

健康人群皮内注射 ChAdOx1 nCoV-19 增强免疫的免疫原性和安全性

期刊:NPJ Vaccines
影响因子:6.9
doi:10.1038/s41541-022-00475-z
Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Chanon Kongkamol, Thammasin Ingv
免疫
新冠
发表日期：2022
文献求助 收藏

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

一项在健康泰国成年人中进行的开放标签随机研究，旨在评估异源性基础免疫接种（包括CoronaVac、ChAdox1 nCov-19和BNT162b2疫苗）以及BNT162b2加强免疫接种对SARS-CoV-2变异株的免疫原性和反应原性。

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2022.2091865
Niyomnaitham, Suvimol; Quan Toh, Zheng; Wongprompitak, Patimaporn; Jansarikit, Laddawan; Srisutthisamphan, Kanjana; Sapsutthipas, Sompong; Jantraphakorn, Yuparat; Mingngamsup, Natthakarn; Licciardi, Paul V; Chokephaibulkit, Kulkanya
SARS-CoV-2
免疫/内分泌
发表日期：2022
文献求助 收藏

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine

新冠病毒疫苗接种方案免疫原性和不良事件的试点研究：先接种灭活全病毒SARS-CoV-2疫苗（CoronaVac），再接种腺病毒载体（ChAdOx1 nCoV-19）疫苗

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines10040536
Mahasirimongkol, Surakameth; Khunphon, Athiwat; Kwangsukstid, Oraya; Sapsutthipas, Sompong; Wichaidit, Mingkwan; Rojanawiwat, Archawin; Wichuckchinda, Nuanjun; Puangtubtim, Wiroj; Pimpapai, Warangluk; Soonthorncharttrawat, Sakulrat; Wanitchang, Asawin; Jongkaewwattana, Anan; Srisutthisamphan, Kanjana; Phainupong, Daraka; Thawong, Naphatcha; Piboonsiri, Pundharika; Sawaengdee, Waritta; Somsaard, Thitiporn; Ritthitham, Kanokphon; Chumpol, Supaporn; Pinyosukhee, Nadthanan; Wichajarn, Rattanawadee; Dhepakson, Panadda; Iamsirithaworn, Sopon; Phumiamorn, Supaporn
微生物学
新冠
SARS-CoV-2
免疫/内分泌
发表日期：2022
文献求助 收藏

Comparison of safety and immunogenicity of CoronaVac and ChAdOx1 against the SARS-CoV-2 circulating variants of concern (Alpha, Delta, Beta) in Thai healthcare workers

比较CoronaVac和ChAdOx1疫苗对泰国医护人员中SARS-CoV-2流行变异株（Alpha、Delta、Beta）的安全性和免疫原性

期刊:Vaccine: X
影响因子:2.2
doi:10.1016/j.jvacx.2022.100153
Angkasekwinai, Nasikarn; Sewatanon, Jaturong; Niyomnaitham, Suvimol; Phumiamorn, Supaporn; Sukapirom, Kasama; Sapsutthipas, Sompong; Sirijatuphat, Rujipas; Wittawatmongkol, Orasri; Senawong, Sansnee; Mahasirimongkol, Surakameth; Trisiriwanich, Sakalin; Chokephaibulkit, Kulkanya
SARS-CoV-2
免疫/内分泌
发表日期：2022
文献求助 收藏

Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates

植物生产的SARS-CoV-2受体结合域在小鼠和非人灵长类动物中引发强效中和反应

期刊:Frontiers in Plant Science
影响因子:4.8
doi:10.3389/fpls.2021.682953
Siriwattananon, Konlavat; Manopwisedjaroen, Suwimon; Shanmugaraj, Balamurugan; Rattanapisit, Kaewta; Phumiamorn, Supaporn; Sapsutthipas, Sompong; Trisiriwanich, Sakalin; Prompetchara, Eakachai; Ketloy, Chutitorn; Buranapraditkun, Supranee; Wijagkanalan, Wassana; Tharakhet, Kittipan; Kaewpang, Papatsara; Leetanasaksakul, Kantinan; Kemthong, Taratorn; Suttisan, Nutchanat; Malaivijitnond, Suchinda; Ruxrungtham, Kiat; Thitithanyanont, Arunee; Phoolcharoen, Waranyoo
SARS-CoV-2
信号转导
Primate
发表日期：2021
文献求助 收藏

Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract

腹膜注射封装在纳米递送系统中的亚单位疫苗，不仅能增强机体对SARS-CoV-2的全身免疫反应，还能刺激呼吸道免疫反应。

期刊:Viruses-Basel
影响因子:3.5
doi:10.3390/v13112202
Jearanaiwitayakul, Tuksin; Apichirapokey, Suttikarn; Chawengkirttikul, Runglawan; Limthongkul, Jitra; Seesen, Mathurin; Jakaew, Phissinee; Trisiriwanich, Sakalin; Sapsutthipas, Sompong; Sunintaboon, Panya; Ubol, Sukathida
SARS-CoV-2
免疫/内分泌
发表日期：2021
文献求助 收藏

Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2

鼻内给药RBD纳米颗粒可诱导针对SARS-CoV-2的黏膜和全身免疫反应。

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines9070768
Jearanaiwitayakul, Tuksin; Seesen, Mathurin; Chawengkirttikul, Runglawan; Limthongkul, Jitra; Apichirapokey, Suttikarn; Sapsutthipas, Sompong; Phumiamorn, Supaporn; Sunintaboon, Panya; Ubol, Sukathida
SARS-CoV-2
免疫/内分泌
发表日期：2021
文献求助 收藏

Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population

健康人群接种两剂灭活 SARS-CoV-2 疫苗后皮内注射 BNT162b2 mRNA 疫苗加强剂的免疫原性和安全性

期刊:Vaccines
影响因子:
doi:10.3390/vaccines9121375
Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
免疫
新冠
发表日期：2021
文献求助 收藏